Perspectives on biomarker and surrogate endpoint evaluation : discussion forum summary

Perspectives on biomarker and surrogate endpoint evaluation discussion forum summary

In 2010 the Institute of Medicine (IOM) recommended a framework for the evaluation of biomarkers in the chronic disease setting. Published in the book Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease, the framework is intended to bring consistency and transparency to the previousl...

Full description

Bibliographic Details
Main Author: Mack, Alison (-)
Corporate Author: Institute of Medicine (U.S.). Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease (-)
Other Authors: Balogh, Erin, Micheel, Christine
Format: eBook
Language:Inglés
Published: Washington, D.C. : National Academies Press 2011.
Edition:1st ed
Subjects:
Biochemical markers.
See on Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009622382706719
Table of Contents:
  • Introduction
  • Committee findings and recommendations
  • FDA perspectives
  • National institutes of health perspectives
  • Industry perspectives
  • Public health, consumer, and consulting organization perspectives
  • Presentation by Thomas Fleming: biomarkers and surrogate endpoints in chronic disease
  • Key themes, challenges, and opportunities
  • Importance of the biomarker discussion forum.

Similar Items